INTERNATIONAL SOCIETY FOR CLINICAL LABORATORY TECHNOLOGY – Trademark Portfolio
Entity Type: 03
INTERNATIONAL SOCIETY FOR CLINICAL LABORATORY TECHNOLOGY holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 16 (Paper Goods) — 3 filings in this category. Currently, 1 trademark is registered. Notable registered marks include P.O.L.T.. The owner is based in ST. LOUIS, MO.
SUITE 918 PAUL BROWN BUILDING
818 OLIVE STREET
ST. LOUIS, MO 63101
Showing of trademarks Trademarks
Trademark Classifications
INTERNATIONAL SOCIETY FOR CLINICAL LABORATORY TECHNOLOGY's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does INTERNATIONAL SOCIETY FOR CLINICAL LABORATORY TECHNOLOGY have?
INTERNATIONAL SOCIETY FOR CLINICAL LABORATORY TECHNOLOGY has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 5 cancelled.
What trademark classes does INTERNATIONAL SOCIETY FOR CLINICAL LABORATORY TECHNOLOGY file in?
INTERNATIONAL SOCIETY FOR CLINICAL LABORATORY TECHNOLOGY files trademarks across 1 Nice Classification class. The most active classes are Class 16 (Paper Goods). Class 16 covers paper and cardboard; printed matter; bookbinding material; photographs; stationery.
What are INTERNATIONAL SOCIETY FOR CLINICAL LABORATORY TECHNOLOGY's most well-known trademarks?
INTERNATIONAL SOCIETY FOR CLINICAL LABORATORY TECHNOLOGY's registered trademark portfolio includes well-known marks such as P.O.L.T.. These are among 1 currently registered trademark in the portfolio.
What is INTERNATIONAL SOCIETY FOR CLINICAL LABORATORY TECHNOLOGY's trademark registration success rate?
INTERNATIONAL SOCIETY FOR CLINICAL LABORATORY TECHNOLOGY has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.